In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 21st, 2008 | 27 | No |
Popular Name: 3-(6-fluoro-1H-indol-3-yl)-4-(1-methylindol-3-yl)pyrrole-2,5-dione 3-(6-fluoro-1H-indol-3-yl)-4-(1-…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.67 | 8.42 | -11.86 | 2 | 5 | 0 | 71 | 359.36 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNE1-2-E | G1/S-specific Cyclin E1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1500 | 0.30 | Binding ≤ 10μM |
CCNE2-2-E | G1/S-specific Cyclin E2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1500 | 0.30 | Binding ≤ 10μM |
CDK2-2-E | Cyclin-dependent Kinase 2 (cluster #2 Of 5), Eukaryotic | Eukaryotes | 1500 | 0.30 | Binding ≤ 10μM |
Z104295-1-O | Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other | Other | 840 | 0.32 | Binding ≤ 10μM |
Z80928-1-O | HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other | Other | 2470 | 0.29 | Functional ≤ 10μM |
Z81024-1-O | NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other | Other | 2580 | 0.29 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 840 | 0.32 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 1500 | 0.30 | Binding ≤ 10μM |
Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 840 | 0.32 | Binding ≤ 10μM |
CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 1500 | 0.30 | Binding ≤ 10μM |
CCNE2_HUMAN | O96020 | G1/S-specific Cyclin E2, Human | 1500 | 0.30 | Binding ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 2470 | 0.29 | Functional ≤ 10μM |
Z81024 | Z81024 | NCI-H460 (Non-small Cell Lung Carcinoma) | 2580 | 0.29 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of the pre-replicative complex | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin E associated events during G1/S transition | |
DNA Damage/Telomere Stress Induced Senescence | |
E2F mediated regulation of DNA replication | |
Factors involved in megakaryocyte development and platelet production | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
Meiotic recombination | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Regulation of APC/C activators between G1/S and early anaphase | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) |